Muco Coccinum

Klebsiella Pneumoniae

Seroyal Usa
Human Otc Drug
NDC 62106-6870

Muco Coccinum also known as Klebsiella Pneumoniae is a human otc drug labeled by 'Seroyal Usa'. National Drug Code (NDC) number for Muco Coccinum is 62106-6870. This drug is available in dosage form of Tablet. The names of the active, medicinal ingredients in Muco Coccinum drug includes Anaerococcus Tetradius - 200 [hp_C]/1 Influenza A Virus - 200 [hp_C]/1 Influenza B Virus - 200 [hp_C]/1 Klebsiella Pneumoniae - 200 [hp_C]/1 Moraxella Catarrhalis Subsp. Catarrhalis - 200 [hp_C]/1 . The currest status of Muco Coccinum drug is Active.

Drug Information:

Drug NDC:	62106-6870
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name:	Muco Coccinum
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type:	Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name:	Klebsiella Pneumoniae
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name:	Seroyal Usa
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form:	Tablet
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status:	Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:	ANAEROCOCCUS TETRADIUS - 200 [hp_C]/1 INFLUENZA A VIRUS - 200 [hp_C]/1 INFLUENZA B VIRUS - 200 [hp_C]/1 KLEBSIELLA PNEUMONIAE - 200 [hp_C]/1 MORAXELLA CATARRHALIS SUBSP. CATARRHALIS - 200 [hp_C]/1
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:	SUBLINGUAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.

Marketing Category:	UNAPPROVED HOMEOPATHIC
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date:	15 Oct, 2014
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date:	08 May, 2026
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Listing Expiration Date:	31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.

Manufacturer Name:	Seroyal USA
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:	Yes
Whether or not the drug has been repackaged for distribution.
UNII:	7Q9DHH4FGG R9HH0NDE2E 1314JZ2X6W 09PA36CT5R 1X259JGO78
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDC	Description	Marketing Start Date	Marketing End Date	Sample Available
62106-6870-0	1 BLISTER PACK in 1 BOX (62106-6870-0) / 10 TABLET in 1 BLISTER PACK	15 Oct, 2014	N/A	No
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Other medicines with the same generic name

Muco Coccinum

Klebsiella Pneumoniae

Tablet
Seroyal USA
NDC: 62106-6870

Purpose:

Uses for the temporary relief of cold and flu-like symptoms

Product Elements:

Muco coccinum klebsiella pneumoniae anaerococcus tetradius anaerococcus tetradius influenza a virus influenza a virus influenza b virus influenza b virus croscarmellose sodium klebsiella pneumoniae klebsiella pneumoniae moraxella catarrhalis subsp. catarrhalis moraxella catarrhalis subsp. catarrhalis lactose magnesium stearate xylitol

Indications and Usage:

Uses for the temporary relief of cold and flu-like symptoms. directions adults and adolescents (12 years and older): at the first sign of symptoms, take one tablet allowing it to dissolve under the tongue. if symptoms persist, take one tablet two or three times during the day or as recommended by your healthcare practitioner. children (6-11 years): take under the direction of your healthcare practitioner.

Warnings:

Warnings this product is not intended to be an alternative to vaccination. do not use if you have ever had an allergic reaction to this product or any of its ingredients. stop use and ask a doctor if symptoms continue to persist after three days of use or are accompanied by a fever. if pregnant or breastfeeding, ask a health professional before use. keep out of reach of children. in case of overdose, get medical help or contact a poison control center right away.

Do Not Use:

Dosage and Administration:

Directions adults and adolescents (12 years and older): at the first sign of symptoms, take one tablet allowing it to dissolve under the tongue. if symptoms persist, take one tablet two or three times during the day or as recommended by your healthcare practitioner. children (6-11 years): take under the direction of your healthcare practitioner.

Overdosage:

In case of overdose, get medical help or contact a poison control center right away.

Package Label Principal Display Panel:

Ndc 62106-6870-0 unda plex mucococcinum homeopathic preparation for the temporary relief of cold and flu-like symptoms. 10 tablets 62106-6870-0

Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.